Biology Reference
In-Depth Information
Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL (2009) Amelioration of intracerebroven-
tricular strepozotion induced cognitive dysfunction and oxidate stress by vinpocetine - a PDE1
inhibitor. Eur J Pharmacol 620:49-56
Devan BD, Sierra-Mercado D Jr, Jimenez M, Bowker JL, Duffy KB, Spangler EL, Ingram DK
(2004) Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment
induced by blockade of cholinergic muscarinic receptors in rats. Pharmacol Biochem Behav
79:691-699
Dhir A, Kulkarni SK (2007a) Effect of addition of yohimbine (alpha-2-receptor antagonist) to the
antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology
80:239-243
Dhir A, Kulkarni SK (2007b) Involvement of nitric oxide (NO) signaling pathway in the
antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568:
177-185
Dlaboga D, Hajjhussein H, O'Donnell JM (2006) Regulation of phosphodiesterase-4 (PDE4)
expression in mouse brain by repeat antidepressant treatment: comparison with rolipram.
Brain Res 1096:104-112
Domek-Łopaci
´
ska KU, Strosznajder JB (2008) The effect of selective inhibition of cyclic GMP
hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide
synthase activity in brain during aging. Brain Res 1216:68-77
Domek-Łopaci
´
ska KU, Strosznajder JB (2010) Cyclic GMP and nitric oxide synthase in aging
and Alzheimer's disease. Mol Neurobiol 41:129-137
Doyle C, Holscher C, Rowan MJ, Anwyl R (1996) The selective neuronal NO synthase inhibitor
7-nitroindazole blocks both long-term potentiation and depotentiation of field EPSPs in rat
hippocampal CA1 in vivo. J Neurosci 16:418-424
Duman RS (2002) Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry
17:306-310
Duman RS, Malberg J, Thome J (1999) Neural plasticity to stress and antidepressant treatment.
Biol Psychiatry 46:1181-1191
Dumaz N, Marais R (2003) Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding
and blocking Raf-1 interaction with Ras. J Biol Chem 278:29819-29823
Dunkern TR, Hatzelmann A (2007) Characterization of inhibitors of phosphodiesterase 1C on
a human cellular system. FEBS J 274:4812-4824
Egan M, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B,
Goldman D, Dean M (2003) The BDNF val66met polymorphism affects activity-dependent
secretion of BDNF and human memory and hippocampal function. Cell 112:257-269
Einat H, Yuan P, Manji HK (2005) Increased anxiety-like behaviors and mitochondrial dysfunc-
tion in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of
mitochondrial function in anxiety disorders. Behav Brain Res 165:172-180
Engels P, Abdel'Al S, Hulley P, Lubbert H (1995) Brain distribution of four rat homologues of the
Drosophila dunce cAMP phosphodiesterase. J Neurosci Res 41:169-178
Epp JR, Spritzer MD, Galea LA (2007) Hippocampus-dependent learning promotes survival
of new neurons in the dentate gyrus at a specific time during cell maturation. Neuroscience
149:273-285
Esposito K, Reierson GW, Luo HR, Wu GS, Licinio J, Wong ML (2009) Phosphodiesterase genes
and antidepressant treatment response: a review. Ann Med 41:177-185
Fatemi SH, King DP, Reutiman TJ, Folsom TD, Laurence JA, Lee S, Fan YT, Paciga SA, Conti M,
Menniti FS (2008) PDE4B polymorphisms and decreased PDE4B expression are associated
with schizophrenia. Schizophr Res 101:36-49
Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA,
Phillips SC (2000) Molecular cloning and characterization of a distinct human phosphodies-
terase gene family: PDE11A. Proc Natl Acad Sci USA 97:3702-3707
